KEGG   PATHWAY: ang04148
Entry
ang04148                    Pathway                                
Name
Efferocytosis - Aspergillus niger (black aspergilli)
Class
Cellular Processes; Transport and catabolism
Pathway map
ang04148  Efferocytosis
ang04148

Organism
Aspergillus niger (black aspergilli) [GN:ang]
Gene
An01g04550  [KO:K20178]
An01g12300  [KO:K20177]
An02g05380  [KO:K20182]
An02g06960  [KO:K20184]
An02g07250  argA; arginase argA-Aspergillus niger [KO:K01476] [EC:3.5.3.1]
An03g06920  [KO:K12366]
An04g02420  [KO:K01581] [EC:4.1.1.17]
An04g02470  [KO:K07888]
An07g02110  [KO:K20183]
An07g03980  [KO:K04441] [EC:2.7.11.24]
An07g04200  [KO:K01052] [EC:3.1.1.13]
An07g10420  [KO:K26935]
An08g03280  [KO:K04718] [EC:2.7.1.91]
An08g04110  [KO:K23678]
An08g05850  [KO:K04441] [EC:2.7.11.24]
An08g10670  [KO:K04371] [EC:2.7.11.24]
An09g06510  [KO:K23678]
An11g00940  [KO:K20179]
An11g10030  [KO:K04392]
An12g04500  [KO:K14802] [EC:7.6.2.1]
An14g01190  [KO:K01476] [EC:3.5.3.1]
An14g04080  [KO:K00411] [EC:7.1.1.8]
An14g05130  [KO:K20180]
An17g01250  [KO:K20181]
An18g02210  [KO:K07897]
An18g03040  [KO:K04459] [EC:3.1.3.16 3.1.3.48]
An18g05270  [KO:K04441] [EC:2.7.11.24]
An18g05870  [KO:K23678]
An18g06290  [KO:K05853] [EC:7.2.2.10]
Compound
C00002  ATP
C00003  NAD+
C00019  S-Adenosyl-L-methionine
C00031  D-Glucose
C00062  L-Arginine
C00073  L-Methionine
C00075  UTP
C00077  L-Ornithine
C00134  Putrescine
C00162  Fatty acid
C00186  (S)-Lactate
C00187  Cholesterol
C00584  Prostaglandin E2
C02530  Cholesterol ester
C02737  Phosphatidylserine
C04230  1-Acyl-sn-glycero-3-phosphocholine
C06124  Sphingosine 1-phosphate
C06314  Lipoxin A4
C15519  25-Hydroxycholesterol
C15610  Cholest-5-ene-3beta,26-diol
C18178  Resolvin D1
Reference
PMID:31822793
  Authors
Doran AC, Yurdagul A Jr, Tabas I
  Title
Efferocytosis in health and disease.
  Journal
Nat Rev Immunol 20:254-267 (2020)
DOI:10.1038/s41577-019-0240-6
Reference
PMID:36028471
  Authors
Zhang J, Ding W, Zhao M, Liu J, Xu Y, Wan J, Wang M
  Title
Mechanisms of efferocytosis in determining inflammation resolution: Therapeutic potential and the association with cardiovascular disease.
  Journal
Br J Pharmacol 179:5151-5171 (2022)
DOI:10.1111/bph.15939
Reference
PMID:30165442
  Authors
Kawano M, Nagata S
  Title
Efferocytosis and autoimmune disease.
  Journal
Int Immunol 30:551-558 (2018)
DOI:10.1093/intimm/dxy055
Reference
PMID:35650427
  Authors
Mehrotra P, Ravichandran KS
  Title
Drugging the efferocytosis process: concepts and opportunities.
  Journal
Nat Rev Drug Discov 21:601-620 (2022)
DOI:10.1038/s41573-022-00470-y
Reference
PMID:28496201
  Authors
Park SY, Kim IS
  Title
Engulfment signals and the phagocytic machinery for apoptotic cell clearance.
  Journal
Exp Mol Med 49:e331 (2017)
DOI:10.1038/emm.2017.52
Reference
PMID:28137963
  Authors
Kojima Y, Weissman IL, Leeper NJ
  Title
The Role of Efferocytosis in Atherosclerosis.
  Journal
Circulation 135:476-489 (2017)
DOI:10.1161/CIRCULATIONAHA.116.025684
Related
pathway
ang00010  Glycolysis / Gluconeogenesis
ang04145  Phagosome
KO pathway
ko04148   

DBGET integrated database retrieval system